Synopsis
Synopsis
0
USDMF
0
NDC API
0
VMF
0
FDA Orange Book
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Anxyrex
2. Apo Bromazepam
3. Apo-bromazepam
4. Beta, Bromazepam
5. Bromalich
6. Bromaz 1a Pharma
7. Bromazanil
8. Bromazep Von Ct
9. Bromazepam Al
10. Bromazepam Beta
11. Bromazepam Heumann
12. Bromazepam Neuraxpharm
13. Bromazepam Ratiopharm
14. Bromazepam-neuraxpharm
15. Bromazepam-ratiopharm
16. Durazanil
17. Gen Bromazepam
18. Gen-bromazepam
19. Lexatin
20. Lexomil
21. Lexotan
22. Lexotanil
23. Ro 5-3350
24. Ro 53350
25. Von Ct, Bromazep
1. Lexotanil
2. Compedium
3. Durazanil
4. Lectopam
5. Lexotan
6. Creosedin
7. Lexaurin
8. Lexilium
9. Lekotam
10. Lexomil
11. 1812-30-2
12. Calmepam
13. Compendium
14. Normoc
15. La Xvii
16. Ro 5-3350
17. Bromazepamum [inn-latin]
18. Lexatin
19. 7-bromo-5-(2-pyridyl)-3h-1,4-benzodiazepin-2(1h)-one
20. 7-bromo-1,3-dihydro-5-(2-pyridyl)-2h-1,4-benzodiazepin-2-one
21. Bromazepam Civ
22. 2h-1,4-benzodiazepin-2-one, 7-bromo-1,3-dihydro-5-(2-pyridinyl)-
23. Nsc 140669
24. 7-bromo-5-pyridin-2-yl-1,3-dihydro-1,4-benzodiazepin-2-one
25. Ultramidol
26. 7-bromo-1,3-dihydro-5-(2-pyridyl)-2h-1,4-benzdiazepin-2-one
27. Nsc-140669
28. 1,3-dihydro-7-bromo-5-(2-pyridyl)-2h-1,4-benzodiazepin-2-one
29. 2h-1,4-benzodiazepin-2-one, 1,3-dihydro-7-bromo-5-(2-pyridyl)-
30. X015l14v0o
31. 2h-1,4-benzodiazepin-2-one, 7-bromo-1,3-dihydro-5-(2-pyridyl)-
32. 7-bromo-5-(2-pyridyl)-3h-1,4-benzodiaxepin-2(1h)-one
33. Bromazepamum
34. Bromazepamum [latin]
35. Ro-5-3350
36. Bromazepam [usan:inn:ban:jan]
37. Lectopam (tn)
38. Einecs 217-322-4
39. Ro 53350
40. Ro 4-9253
41. Brn 0618645
42. 7-bromo-5-[2-pyridyl]-3h-1,4-benzodiaxepin-2[1h]-one
43. Unii-x015l14v0o
44. Dea No. 2748
45. Bromazepam [mi]
46. Bromazepam [inn]
47. Bromazepam [jan]
48. Bromazepam [usan]
49. Bromazepam [mart.]
50. Bromazepam [who-dd]
51. Schembl43933
52. 5-26-05-00078 (beilstein Handbook Reference)
53. Mls003899212
54. Bromazepam, Analytical Standard
55. Chembl277062
56. Zinc1051
57. Bromazepam (jp17/usan/inn)
58. Bromazepam Civ [usp-rs]
59. Chebi:31302
60. Bromazepam [ep Monograph]
61. Dtxsid40171081
62. 7-bromo-1,4-benzodiazepin-2-one
63. Bromazepam 0.1 Mg/ml In Methanol
64. Bromazepam 1.0 Mg/ml In Methanol
65. Nsc140669
66. Db01558
67. Smr000058724
68. Wln: T67 Gmv Jn Ihj Ce K- Bt6nj
69. D01245
70. 2h-1, 7-bromo-1,3-dihydro-5-(2-pyridyl)-
71. 2h-1, 7-bromo-1,3-dihydro-5-(2-pyridinyl)-
72. 812b302
73. Bromazepam, Drug Standard, 1.0 Mg/ml In Methanol
74. Q422435
75. Bromazepam, European Pharmacopoeia (ep) Reference Standard
76. Bromazepam, United States Pharmacopeia (usp) Reference Standard
77. 7-bromo-5-(pyridin-2-yl)-1h-benzo[e][1,4]diazepin-2(3h)-one
78. 7-bromo-5-(pyridin-2-yl)-2,3-dihydro-1h-1,4-benzodiazepin-2-one
79. (e)-7-bromo-5-(pyridin-2-yl)-1h-benzo[e][1,4]diazepin-2(3h)-one
80. 7-bromo-5-(2-pyridinyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-one #
81. Bromazepam Solution, 1.0 Mg/ml In Methanol, Ampule Of 1 Ml, Certified Reference Material
| Molecular Weight | 316.15 g/mol |
|---|---|
| Molecular Formula | C14H10BrN3O |
| XLogP3 | 1.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 315.00072 g/mol |
| Monoisotopic Mass | 315.00072 g/mol |
| Topological Polar Surface Area | 54.4 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 385 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
For the short-term treatment of insomnia, short-term treatment of anxiety or panic attacks, if a benzodiazepine is required, and the alleviation of the symptoms of alcohol- and opiate-withdrawal.
Bromazepam is a lipophilic, long-acting benzodiazepine and with sedative, hypnotic, anxiolytic and skeletal muscle relaxant properties. It does not possess any antidepressant qualities. Bromazepam, like other benzodiazepines, presents a risk of abuse, misuse, and dependence. According to many psychiatric experts, Bromazepam has a greater abuse potential than other benzodiazepines because of fast resorption and rapid onset of action.
GABA Modulators
Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
N05BA08
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
N - Nervous system
N05 - Psycholeptics
N05B - Anxiolytics
N05BA - Benzodiazepine derivatives
N05BA08 - Bromazepam
Absorption
Bioavailability is 84% following oral administration. The time to peak plasma level is 1 - 4 hours. Bromazepam is generally well absorbed after oral administration.
Route of Elimination
Urine (69%), as metabolites
Volume of Distribution
1.56 L/kg
Clearance
0.82 mL/min/kg.
Hepatically, via oxidative pathways (via an enzyme belonging to the Cytochrome P450 family of enzymes). One of the main metabolites is 3-hydroxybromazepam. It is pharmacologically active and the half life is similar to that of the parent compound.
Bromazepam has known human metabolites that include 3-Hydroxybromazepam.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
10-20 hours
Bromazepam binds to the GABA-A receptor producing a conformational change and potentiating its inhibitory effects. Other neurotransmitters are not influenced.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
Certificate Number : R1-CEP 2008-318 - Rev 01
Status : Valid
Issue Date : 2017-12-20
Type : Chemical
Substance Number : 879
Certificate Number : CEP 2004-172 - Rev 04
Status : Valid
Issue Date : 2023-10-19
Type : Chemical
Substance Number : 879
Certificate Number : R1-CEP 2005-073 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2016-03-03
Type : Chemical
Substance Number : 879
Certificate Number : R1-CEP 2004-034 - Rev 02
Status : Valid
Issue Date : 2014-02-24
Type : Chemical
Substance Number : 879
Certificate Number : R1-CEP 2010-053 - Rev 00
Status : Valid
Issue Date : 2016-03-16
Type : Chemical
Substance Number : 879
Certificate Number : R1-CEP 1998-150 - Rev 02
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2007-07-03
Type : Chemical
Substance Number : 879
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
Date of Issue : 2022-06-08
Valid Till : 2025-06-25
Written Confirmation Number : WC-0107
Address of the Firm : Plot No. 75/76, Chikhloli, MIDC, Ambernath (W), Dist- Thane
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0101
Address of the Firm : 21-M Attibele Industrial Area, Anekal Taluk, Bangalore-562107
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Nortec Quimica is the largest API manufacturer in Latin America.
About the Company : Nortec Química stands as the largest manufacturer of Active Pharmaceutical Ingredients (IFAs) in Latin America, embarking on its mission to ensure the availability of quality medi...
About the Company : BIOTECHNICA DWC LLC has carved a niche for itself in providing value added compliance, regulatory qualification, project management and GDP guidance services to pharma companies al...
About the Company : Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years...
About the Company : Centaur accepts change as a constant, and continuously innovates to remain significant. Centaur has built knowledge sharing relationships with the pharmaceutical majors in areas of...
About the Company : Formil QuImica Ltd is a Brazilian company located in BaruerI - SP. We produce through chemical synthesis or extraction and commercialize API (Active Pharmaceutical Ingredient) on l...
About the Company : We are a 100% Mexican company certified in Good Manufacturing Practices (GMP). We have been in the business of manufacturing Active Pharmaceutical Ingredients (API´s) for more tha...
About the Company : Lake Chemicals is specialized in Benzodiazepine and CNS range of products such as Alprazolam, Bromazepam, Clobazam, Clonazepam, Midazolam Salts, Lorazepam, Olanzapine Form-1 etc. H...
About the Company : Our work in the distribution sector starts and ends with the quality of human relations; first and foremost, it is trust that we want to build with you. The connections we build ar...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
APIs
Reply
05 Jun 2023
Reply
30 Jun 2022
Reply
16 Feb 2022
Reply
10 Dec 2021
Reply
08 Nov 2021
Reply
26 Sep 2019
Reply
07 Feb 2019
Reply
17 May 2018
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
Comment (9)
